Caliway Biopharmaceuticals Revenue

Caliway Biopharmaceuticals had revenue of 23.26M TWD in the quarter ending September 30, 2024, with 101.74% growth. This brings the company's revenue in the last twelve months to 49.98M, up 64.40% year-over-year. In the year 2023, Caliway Biopharmaceuticals had annual revenue of 38.93M with 203.68% growth.

Revenue (ttm)

49.98M

Revenue Growth

+64.40%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

90.07B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	38.93M	26.11M	203.68%
Dec 31, 2022	12.82M	481.00K	3.90%
Dec 31, 2021	12.34M	1.99M	19.22%
Dec 31, 2020	10.35M	-8.30M	-44.50%
Dec 31, 2019	18.65M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	8.32B
Bora Pharmaceuticals Co., LTD.	16.71B
Lotus Pharmaceutical	17.59B
Oneness Biotech	112.20M
Lumosa Therapeutics	37.82M
Polaris Group	75.65M
Center Laboratories	1.57B
Pegavision	7.06B

Revenue Rankings